Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_assertion description "[Over the last few years, excitement over this class of agents has escalated due to reported activity as single agent in BRCA1- or BRCA2-associated ovarian or breast cancers, and in combination with chemotherapy in triple negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_assertion evidence source_evidence_literature NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_assertion SIO_000772 21718592 NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_assertion wasDerivedFrom befree-2016 NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_assertion wasGeneratedBy ECO_0000203 NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.
- befree-2016 importedOn "2016-02-19" NP906164.RA4MTSG0UwdtGVHZ-g3nX_Yq2Zwhq6j0ZN3n_HjT91Hm0130_provenance.